MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
333.53%
Quick Ratio
277.76%
Cash Ratio
44.40%
Debt to Asset Ratio
24.01%
Unit: Thousand (K) dollars
Assets Breakdown
Total current assets
Marketable securities
Property, plant, and equipment, ...
Others
Liabilities Breakdown
Retained earnings
Treasury stock, at cost 36.4 sha...
Additional paid-in capital
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
2,455,800
2,962,600
3,118,100
2,506,400
Marketable securities
5,538,800
5,791,100
5,487,100
5,937,200
Accounts receivable, net
6,565,400
5,731,000
5,741,100
5,687,100
Inventories
3,084,300
3,103,600
3,200,800
3,254,400
Prepaid expenses and other current assets
801,700
620,900
474,800
595,600
Total current assets
18,446,000
18,209,200
18,021,900
17,980,700
Marketable securities
9,828,300
9,786,000
10,260,600
10,285,700
Property, plant, and equipment, net
5,458,900
5,266,100
5,120,400
5,002,300
Intangible assets, net
1,309,800
1,286,900
1,257,400
1,380,900
Deferred tax assets
4,381,400
4,190,900
4,077,200
3,846,700
Other noncurrent assets
2,306,200
2,129,700
1,821,200
1,673,100
Total assets
41,730,600
40,868,800
40,558,700
40,169,400
Accounts payable
1,159,300
1,027,100
939,000
903,800
Accrued expenses and other current liabilities
2,966,500
2,724,400
2,876,400
2,975,700
Finance lease liabilities
720,000
720,000
-
-
Deferred revenue
684,800
636,200
553,000
545,600
Total current liabilities
5,530,600
5,107,700
4,368,400
4,425,100
Long-term debt
1,986,600
1,986,200
1,985,900
1,985,500
Finance lease liabilities
0
0
720,000
720,000
Deferred revenue
220,400
225,100
208,700
219,200
Other noncurrent liabilities
2,281,600
2,126,200
2,018,800
1,861,800
Total liabilities
10,019,200
9,445,200
9,301,800
9,211,600
Common stock-Common Class A
0
0
0
0
Common stock-Common Stock
100
100
100
100
Additional paid-in capital
14,700,600
14,401,300
13,995,000
13,787,300
Retained earnings
37,621,400
36,423,800
35,797,100
35,045,800
Accumulated other comprehensive (loss) income
-35,800
11,900
77,500
69,000
Treasury stock, at cost 36.4 shares in 2026 and 33.7 shares in 2025
20,574,900
19,413,500
18,612,800
17,944,400
Total stockholders' equity
31,711,400
31,423,600
31,256,900
30,957,800
Total liabilities and stockholders' equity
41,730,600
40,868,800
40,558,700
40,169,400
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Accounts receivable, net
$6,565,400K
(17.03%↑ Y/Y)
Marketable securities
$5,538,800K
(1.19%↑ Y/Y)
Inventories
$3,084,300K
(-3.78%↓ Y/Y)
Cash and cash
equivalents
$2,455,800K
(23.05%↑ Y/Y)
Prepaid expenses and
other current assets
$801,700K
(39.60%↑ Y/Y)
Total current assets
$18,446,000K
(9.41%↑ Y/Y)
Marketable securities
$9,828,300K
(-2.29%↓ Y/Y)
Property, plant, and
equipment, net
$5,458,900K
(12.77%↑ Y/Y)
Deferred tax assets
$4,381,400K
(22.65%↑ Y/Y)
Other noncurrent
assets
$2,306,200K
(50.06%↑ Y/Y)
Intangible assets, net
$1,309,800K
(-3.10%↓ Y/Y)
Total assets
$41,730,600K
(9.19%↑ Y/Y)
Total liabilities and
stockholders' equity
$41,730,600K
(9.19%↑ Y/Y)
Total stockholders'
equity
$31,711,400K
(5.92%↑ Y/Y)
Total liabilities
$10,019,200K
(21.00%↑ Y/Y)
Treasury stock, at cost
36.4 shares in 2026...
$20,574,900K
(19.04%↑ Y/Y)
Accumulated other
comprehensive (loss) income
-$35,800K
(-168.19%↓ Y/Y)
Retained earnings
$37,621,400K
(11.70%↑ Y/Y)
Total current
liabilities
$5,530,600K
(50.82%↑ Y/Y)
Other noncurrent
liabilities
$2,281,600K
(34.06%↑ Y/Y)
Long-term debt
$1,986,600K
(0.08%↑ Y/Y)
Deferred revenue
$220,400K
(6.83%↑ Y/Y)
Additional paid-in capital
$14,700,600K
(8.97%↑ Y/Y)
Common stock-Common
Stock
$100K
(0.00%↑ Y/Y)
Accrued expenses and
other current...
$2,966,500K
(20.53%↑ Y/Y)
Accounts payable
$1,159,300K
(60.15%↑ Y/Y)
Finance lease
liabilities
$720,000K
(0.00%↑ Y/Y)
Deferred revenue
$684,800K
(42.10%↑ Y/Y)
Buy us a coffee
REGN_BIG copy-svg-svg-svg
REGENERON PHARMACEUTICALS, INC. (REGN)
REGN_BIG copy-svg-svg-svg
REGENERON PHARMACEUTICALS, INC. (REGN)
🚨
Price Alert:
The stock price jumped by 13.38% after the earning call.